Analystreport

Iterum Therapeutics PLC (NASDAQ: ITRM) was given a new $20.00 price target on by analysts at Needham & Company LLC. They now have a "buy" rating on the stock.

Iterum Therapeutics plc - Ordinary Share  (ITRM) 
Last iterum therapeutics plc - ordinary share earnings: 11/12 04:30 pm Check Earnings Report